echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > From "fighting alone" to "fighting together", traditional medicines synergize

    From "fighting alone" to "fighting together", traditional medicines synergize

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professionals only

    A new chapter in ra combination therapy has begun and we are looking for the best partner



    References[1]Ishiguro N, Yamamoto K, Katayama K, et al.
    Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial.
    Mod Rheumatol[J].
    2013, 23(3): 430-439.
    [2] Hara M, Ishiguro N, Katayama K, et al.
    Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial[J].
    Mod Rheumatol.
    2014, 24(3): 410-418.

    Zhang Jiayong, Guo Jin, Shen Jie, et al.
    Clinical observation of MTX combined with Ellamod in the treatment of refractory rheumatoid arthritis[J].
    China Medical Guide, 2014(1): 98-99.

    Ding Ling, He Shanzhi, Wang Min, et al.
    Efficacy of Erarmod on Elderly Rheumatoid Arthritis and Its Bone Metabolism Analysis[J].
    Jilin Medicine.
    2019, 40(06): 1269-1270.

    Dai Lu, Song Xinli, Qiu Xiaoming, et al.
    Effect of Ellamod combined with leflunomide in the treatment of moderate and severe geriatric active rheumatoid arthritis[J].
    Journal of Practical Clinical Medicine.
    2019, 23(3): 73-77.

    Tian Xinping, Liu Shengyun, Li Qin, et al.
    Efficacy and safety comparison of Ellamod or leflunomide combined with methotrexate in the treatment of active rheumatoid arthritis: a multicenter, randomized, double-blind, double-analog-controlled clinical study[J].
    2020, 24(3): 148-158.

    Niu Min, Yan Meixi, Gao Jie, et al.
    Effects of Ellamod and Leflunomide in the treatment of rheumatoid arthritis on bone metabolism and serum IgA, IgG and IgM in patients[J].
    Hainan Medical Journal, 2021, 32(10): 1252-1255.

    ZHANG Lingling.
    Changes in bone metabolic indexes, clinical efficacy and safety of Ellamod before and after 24 weeks of treatment in patients with moderate to severe rheumatoid arthritis[J].
    Contemporary Medicine, 2021, 27(21):52-54.

    Cheng Baoxiang,Hu Xiaofang.
    Efficacy of methotrexate in combination with elamold and hydroxychloroquine in the treatment of rheumatoid arthritis[J].
    Primary Care Forum, 2021, 25(32): 4630-4631.

    Liu Changlian, He Dongdong, Li Xiaoming, et al.
    Efficacy of Ellamod in the treatment of rheumatoid arthritis and its effect on immuno-inflammatory factor levels and bone metabolism indexes in patients[J].
    Shaanxi Medical Journal, 2020, 49(5): 603-607.

    MA Ling.
    Efficacy of Elamod combined with methotrexate in the treatment of rheumatoid arthritis[J].
    Aesthetic Medicine, 2014, (9): 265-266.

    [12] Nozaki Y, Oribe M, Tomita D, et al.
    Iguratimod Versus Salazosulfapyridine in Rheumatoid Arthritis Patients with an Inadequate Response to Methotrexate: Adjusted with Propensity Score Matching[J].
    Mod Rheumatol.
    2022.
    doi: 10.
    1093/mr/roac060.
    This article is only used to provide scientific information to healthcare professionals and does not represent the position of the
    Platform.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.